2017
DOI: 10.18553/jmcp.2017.23.11.1130
|View full text |Cite
|
Sign up to set email alerts
|

How Stakeholder Assessment of E-Prescribing Can Help Determine Incentives to Facilitate Management of Care: A Delphi Study

Abstract: This research was supported by the National Library of Medicine of the National Institutes of Health under Award Number T15LM007088. The authors declare no conflicts of interest in the research. Study concept and design were contributed by DeMuro, Ash, Middleton, and Fletcher. DeMuro took the lead in data collection, along with Ash, and data interpretation was performed by DeMuro, Ash, Madison, Middleton, and Fletcher. The manuscript was written primarily by DeMuro, along with Ash and Middleton, and revised by… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2018
2018
2020
2020

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 23 publications
0
2
0
Order By: Relevance
“…The hospital locations were divided into urban and rural areas. The comorbidities were selected using the Charlson Comorbidity Index (CCI), a method of categorizing comorbidities based on the ICD-10 codes, and grouped based on the CCI scores 0-1, 2, and ≥ 3 [12]. Specific comorbidities included hypertension (ICD-10: I10), diabetes mellitus (ICD-10: E10, E11), myocardial infarction (ICD-10: I21, I22), and end-stage renal diseases (ICD-10: N18.5).…”
Section: Variables Of Interestmentioning
confidence: 99%
“…The hospital locations were divided into urban and rural areas. The comorbidities were selected using the Charlson Comorbidity Index (CCI), a method of categorizing comorbidities based on the ICD-10 codes, and grouped based on the CCI scores 0-1, 2, and ≥ 3 [12]. Specific comorbidities included hypertension (ICD-10: I10), diabetes mellitus (ICD-10: E10, E11), myocardial infarction (ICD-10: I21, I22), and end-stage renal diseases (ICD-10: N18.5).…”
Section: Variables Of Interestmentioning
confidence: 99%
“…This prism of evaluation of electronic prescriptions in the health services, regarding the postive and negative aspects, is thematic in recent studies 10,11 , which stand out, beyond the perspectives of the health professionals who perform the prescription, the perspectives of the care patients and those of the health managers.…”
mentioning
confidence: 99%